|
CONSOLIDATED STATEMENTS OF CASH FLOWS |
| |||||||||
|
(Unaudited) |
| |||||||||
|
|
Three Months Ended |
|
Year Ended |
| ||||||
|
|
June 30, |
|
March 31, |
|
June 24, |
|
June 30, |
|
June 24, |
|
|
|
2018 |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
|
|
|
(in thousands) |
| ||||||||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ 194,172 |
|
$ 193,627 |
|
$ 163,309 |
|
$ 467,318 |
|
$ 571,613 |
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
19,753 |
|
20,605 |
|
17,624 |
|
78,685 |
|
71,117 |
|
|
Depreciation and amortization |
36,083 |
|
36,324 |
|
38,194 |
|
144,974 |
|
164,292 |
|
|
Deferred taxes |
21,458 |
|
(2,670) |
|
1,697 |
|
27,715 |
|
(7,895) |
|
|
Loss (gain) from sale of property, plant and equipment |
423 |
|
1,160 |
|
7,006 |
|
995 |
|
16,365 |
|
|
Loss (gain) on sale of business |
— |
|
— |
|
— |
|
— |
|
(26,620) |
|
|
Impairment of long-lived assets |
— |
|
— |
|
665 |
|
42 |
|
1,462 |
|
|
Impairment of investment in privately-held companies |
— |
|
— |
|
— |
|
850 |
|
6,720 |
|
|
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
40,480 |
|
(80,953) |
|
1,138 |
|
(19,714) |
|
78 |
|
|
Inventories |
(9,450) |
|
(11,036) |
|
(5,715) |
|
(32,776) |
|
(21,215) |
|
|
Other current assets |
(212) |
|
(367) |
|
(727) |
|
32,368 |
|
(3,547) |
|
|
Accounts payable |
6,131 |
|
(235) |
|
(5,235) |
|
9,560 |
|
(6,205) |
|
|
Income taxes payable |
(163,010) |
|
30,067 |
|
22,619 |
|
117,654 |
|
60,798 |
|
|
Deferred margin on shipments to distributors |
— |
|
— |
|
(20,751) |
|
(14,974) |
|
(23,805) |
|
|
Accrued salary and related expenses |
3,911 |
|
33,408 |
|
9,597 |
|
5,737 |
|
(21,399) |
|
|
All other accrued liabilities |
(3,080) |
|
3,295 |
|
7,507 |
|
1,030 |
|
(8,102) |
|
|
Net cash provided by (used in) operating activities |
146,659 |
|
223,225 |
|
236,928 |
|
$819,464 |
|
773,657 |
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
Purchase of property, plant and equipment |
(12,118) |
|
(16,930) |
|
(13,050) |
|
(65,782) |
|
(51,421) |
|
|
Proceeds from sales of property, plant and equipment |
62 |
|
2,844 |
|
7,576 |
|
5,823 |
|
10,792 |
|
|
Proceeds from sale of available-for-sale securities |
7,287 |
|
60,008 |
|
— |
|
107,291 |
|
50,994 |
|
|
Proceeds from maturity of available-for-sale securities |
330,749 |
|
304,289 |
|
50,000 |
|
753,249 |
|
75,000 |
|
|
Proceeds from sale of business |
— |
|
— |
|
— |
|
— |
|
42,199 |
|
|
Payment in connection with business acquisition, net of cash acquired |
— |
|
(57,773) |
|
— |
|
(57,773) |
|
— |
|
|
Purchases of available-for-sale securities |
(325,063) |
|
(268,821) |
|
(49,891) |
|
(1,447,354) |
|
(450,135) |
|
|
Purchases of privately-held companies' securities |
(2,164) |
|
(1,250) |
|
— |
|
(5,520) |
|
(2,825) |
|
|
Net cash provided by (used in) investing activities |
(1,247) |
|
22,367 |
|
(5,365) |
|
(710,066) |
|
(325,396) |
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
Net issuance of restricted stock units |
(9,148) |
|
(9,642) |
|
(7,471) |
|
(30,310) |
|
(25,183) |
|
|
Repayment of notes payable |
— |
|
— |
|
— |
|
— |
|
(250,000) |
|
|
Issuance of debt |
— |
|
— |
|
500,000 |
|
— |
|
500,000 |
|
|
Debt issuance cost |
— |
|
— |
|
(3,688) |
|
— |
|
(3,688) |
|
|
Proceeds from stock options exercised |
1,626 |
|
7,716 |
|
18,434 |
|
28,009 |
|
63,003 |
|
|
Issuance of common stock under employee stock purchase program |
21,346 |
|
— |
|
19,805 |
|
36,321 |
|
34,269 |
|
|
Repurchase of common stock |
(128,024) |
|
(127,700) |
|
(75,853) |
|
(407,968) |
|
(251,799) |
|
|
Dividends paid |
(117,321) |
|
(117,883) |
|
(93,396) |
|
(438,087) |
|
(373,971) |
|
|
Net cash provided by (used in) financing activities |
(231,521) |
|
(247,509) |
|
357,831 |
|
(812,035) |
|
(307,369) |
|
|
Net increase (decrease) in cash and cash equivalents |
(86,109) |
|
(1,917) |
|
589,394 |
|
(702,637) |
|
140,892 |
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
$1,629,593 |
|
$1,631,510 |
|
$1,656,727 |
|
$2,246,121 |
|
$2,105,229 |
|
|
End of period |
$1,543,484 |
|
$1,629,593 |
|
$2,246,121 |
|
$1,543,484 |
|
$2,246,121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents, and short-term investments |
$2,626,399 |
|
$2,724,394 |
|
$2,744,839 |
|
$2,626,399 |
|
$2,744,839 |
|
|
|
|
|
|
|
|
|
|
|
|
|